LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image-Based AI Shows Promise for Parasite Detection in Digitized Stool Samples

By LabMedica International staff writers
Posted on 17 Apr 2024
Image: AI played critical role in intestinal worm infection screening among children in Kenya (Photo courtesy of University of Helsinki)
Image: AI played critical role in intestinal worm infection screening among children in Kenya (Photo courtesy of University of Helsinki)

Infections from soil-transmitted helminths (STHs), commonly known as intestinal parasitic worms, are among the most widespread neglected tropical diseases and impose a significant health burden in low- and middle-income countries, particularly among school-aged children. These infections often lead to chronic health issues that can cause disability, social stigma, and for their substantial economic impacts on communities. STHs are notorious role in nutrient loss, which can contribute to neurocognitive impairments, stunted growth and development, and persistent fatigue in affected children. Additionally, these parasites are a major cause of morbidity and complications during pregnancy. The standard diagnostic method for STHs involves manual microscopy, which requires up to 10 minutes per slide and is hindered by a lack of skilled professionals and access to necessary equipment and lab infrastructure in highly affected regions. There is a pressing need for improved diagnostic techniques, particularly for detecting infections of mild intensity, to effectively manage and aim for the elimination of STHs as a public health concern. Now, an artificial intelligence (AI) microscopy system has been shown to accurately identify intestinal worm infections, especially light-intensity infections that could be overlooked when using manual microscopy.

The new study by a multi-institutional team of specialists from the Karolinska Institute (Stockholm, Sweden) and University of Helsinki (Helsinki, Finland) marked the first clinical trial of the system to detect worm infections in a remote setting with whole-slide images. The study was carried out in rural areas of Kwale County, Kenya, where there is a high prevalence of STHs among children. During the study, 1,335 school-aged children were screened using the deep learning-based system for parasitic worm egg detection, with results compared against those obtained through expert manual microscopy.

The analysis of digitally scanned stool samples using the deep learning system demonstrated high diagnostic accuracy in identifying three common types of parasitic worms: Ascaris lumbricoides (giant roundworm), Trichuris trichiura (whipworm), and hookworm (Ancylostoma duodenale or Necator americanus). The AI was able to detect between 76% and 92% of the infections identified by trained lab technicians, depending on the type of worm. Notably, the AI system identified a significant number of light-intensity infections that were missed in manual microscopy evaluations. In fact, in 79 samples (10% of the total), which were initially determined to be negative by manual microscopy, the AI system detected the presence of parasitic worm eggs. Moreover, the AI system provides a digital record of each sample that can be preserved for further analysis, offering a significant advantage over human samples, which typically dry out within hours and become more challenging for further analysis.

“We have shown that we can use our testing in a resource-limited setting and get high accuracy. Our method was especially efficient in light-intensity infections,” said Principal Investigator Professor Johan Lundin, MD, PhD, from the Karolinska Institutet. “With AI, once our sample is digitised, it takes just a few second and looks at the entire sample and is able to very accurately find the parasite eggs.”

Related Links:
Karolinska Institute
University of Helsinki

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more